Multiple Sclerosis: Pathology

Multiple Sclerosis (MS) is a demyelinating autoimmune disease of the central nervous system. Symptoms include optic neuritis and motor weakness. Here is the latest research on the pathology of this complex neurodegenerative disease.

January 11, 2021

Altered structural networks in neuromyelitis optica spectrum disorder related with cognition impairment and clinical features

Multiple Sclerosis and Related Disorders
Qiao ZhengYongmei Li
December 29, 2020
Open Access

GAMER MRI: Gated-attention mechanism ranking of multi-contrast MRI in brain pathology.

NeuroImage. Clinical
Po-Jui LuC. Granziera
December 19, 2020
Open Access

Epigenetic differences at the HTR2A locus in progressive multiple sclerosis patients

Scientific Reports
Vicki E MaltbyJeannette Lechner-Scott
January 1, 2021

Mesenchymal stem cells instruct a beneficial phenotype in reactive astrocytes

Tiziana VigoAntonio Uccelli
January 7, 2021
Open Access

Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Rosario CaltabianoPaolo Fagone
December 29, 2020
Open Access

Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis

Brain Pathology
Maria T SekyiSeema K Tiwari-Woodruff
January 14, 2021
Open Access

CCR6 blockade on regulatory T cells ameliorates experimental model of multiple sclerosis

Central-European Journal of Immunology
Izabela Jatczak-PawlikAndrzej Glabinski
January 8, 2021

Thrombin generation and activity in multiple sclerosis

Metabolic Brain Disease
Kelley R JordanNorah G Verbout
December 17, 2020
Open Access

The Relationship of the Mechanisms of the Pathogenesis of Multiple Sclerosis and the Expression of Endogenous Retroviruses

Vera R LezhnyovaAlbert A Rizvanov
December 18, 2020
Open Access

RANK/RANKL/OPG Signaling in the Brain: A Systematic Review of the Literature

Frontiers in Neurology
Anton GlasnovićSrećko Gajović
January 12, 2021
Open Access

Intestinal Microbes in Autoimmune and Inflammatory Disease

Frontiers in Immunology
Wan-Jung H WuGretchen E Diehl
December 29, 2020

Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalitis (EAE)-related pain

Brain, Behavior, and Immunity
Andrew J KwilaszLinda R Watkins
January 14, 2021
Open Access

Effectiveness of Motor Imagery on Motor Recovery in Patients with Multiple Sclerosis: Systematic Review

International Journal of Environmental Research and Public Health
Ana Gil-Bermejo-Bernardez-ZerpaCarlos Luque-Moreno
January 14, 2021

Mind the gap: from neurons to networks to outcomes in multiple sclerosis

Nature Reviews. Neurology
Declan T ChardMAGNIMS Study Group

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

© 2021 Meta ULC. All rights reserved